fluorodeoxyglucose f18 has been researched along with Opsoclonus-Myoclonus Syndrome in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jeong, HJ; Jeong, YJ; Lim, ST; Na, CJ; Sohn, MH | 1 |
Boegle, R; Dieterich, M; Ertl, M; Eulenburg, PZ; Kim, JS; Oh, SY | 1 |
2 other study(ies) available for fluorodeoxyglucose f18 and Opsoclonus-Myoclonus Syndrome
Article | Year |
---|---|
18F-FDG PET/CT Brain Imaging on a Patient With Paraneoplastic Opsoclonus-Myoclonus Syndrome Arising out of a Mature Cystic Teratoma.
Topics: Brain Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Opsoclonus-Myoclonus Syndrome; Positron-Emission Tomography; Radiopharmaceuticals; Teratoma; Tomography, X-Ray Computed; Young Adult | 2016 |
Longitudinal multi-modal neuroimaging in opsoclonus-myoclonus syndrome.
Topics: Brain; Brain Mapping; Female; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Multimodal Imaging; Neural Pathways; Opsoclonus-Myoclonus Syndrome; Positron-Emission Tomography; Radiopharmaceuticals; Rest; Young Adult | 2017 |